Nephros
NEPH
19 hedge funds and large institutions have $9.18M invested in Nephros in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% more funds holding
Funds holding: 18 → 19 (+1)
0.64% more ownership
Funds ownership: 40.46% → 41.1% (+0.64%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
2% less capital invested
Capital invested by funds: $9.4M → $9.18M (-$214K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$41.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.6K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$38K |
| 4 |
IFG
Independent Financial Group
San Diego,
California
|
+$25.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$25.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$25.4K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$8.16K |
| 3 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
-$3.42K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$2.16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.57K |
NEPH Hedge Fund Activity: Q2 2024 in Review
19 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q2 2024, worth a combined $9.18M — down 2.3% from $9.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NEPH positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, adding an estimated $41.1K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $25.4K sold.
- 19 institutional investors held Nephros (NEPH) as of Q2 2024, up from 18 in Q1 2024.
- Funds reported $9.18M of Nephros stock for Q2 2024, down 2.3% quarter-over-quarter.
- 4 funds opened new Nephros positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest Nephros buyer in Q2 2024 was UBS Group, an estimated $41.1K added.
- The largest Nephros seller in Q2 2024 was Two Sigma Securities, an estimated $25.4K sold.
Based on aggregated 13F filings for Q2 2024.